Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic can even cut risk of Alzheimer’s disease, study says
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
New Alzheimer’s drug approved in UK
UK regulator approves second Alzheimer's drug in months but government won't pay for it
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to t
New Alzheimer’s drug approved in UK, but government won’t pay for it
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months. View on euronews
Alzheimer's Society responds to approval of new Alzheimer's drug
The Alzheimer's Society Cymru has responded to the approval of a new Alzheimer's treatment. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on Wednesday, October 23, that it has approved the drug donanemab.
FierceBiotech
2h
Eisai, Eli Lilly didn’t disclose heightened brain injury risk to Alzheimer’s trial patients: NYT
A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two ...
studyfinds
1h
Ozempic for Alzheimer’s disease? Popular weight loss drug may also protect the brain
Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.
4d
on MSN
Alzheimer's disease may damage the brain in two phases
Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping ...
health enews
22h
Do’s and don’ts: Caring for a loved one with Alzheimer’s disease
When caring for a loved one with Alzheimer’s disease, be patient and repeat when necessary, plan ahead and use memory cues.
7d
on MSN
Alzheimer's disease might damage brain in two phases
Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...
6h
Breakthrough Discovery: Freezing Alzheimer’s Progress by Pausing Amyloid Fibrils
Researchers have identified a key mechanism in the development of Alzheimer's disease involving the growth and pause of ...
WKBW
14h
Researchers at UB working to create vaccine to treat Alzheimer's disease
There have been many promising leads for an Alzheimer's vaccine but new treatments have been slow to merge. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
United Kingdom
Novo Nordisk
Wegovy
Massachusetts
Feedback